DE69332433T2 - Verbesserte aminosaureloesungen zur behandlung bei peritonealer dialyse - Google Patents

Verbesserte aminosaureloesungen zur behandlung bei peritonealer dialyse

Info

Publication number
DE69332433T2
DE69332433T2 DE69332433T DE69332433T DE69332433T2 DE 69332433 T2 DE69332433 T2 DE 69332433T2 DE 69332433 T DE69332433 T DE 69332433T DE 69332433 T DE69332433 T DE 69332433T DE 69332433 T2 DE69332433 T2 DE 69332433T2
Authority
DE
Germany
Prior art keywords
amino acid
peritoneal dialysis
acid solutions
dialysis treatment
improved amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69332433T
Other languages
English (en)
Other versions
DE69332433D1 (de
Inventor
Leo Martis
Michael R Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter International Inc filed Critical Baxter International Inc
Publication of DE69332433D1 publication Critical patent/DE69332433D1/de
Application granted granted Critical
Publication of DE69332433T2 publication Critical patent/DE69332433T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor
DE69332433T 1992-12-22 1993-12-10 Verbesserte aminosaureloesungen zur behandlung bei peritonealer dialyse Expired - Lifetime DE69332433T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99585592A 1992-12-22 1992-12-22
PCT/US1993/012077 WO1994014430A1 (en) 1992-12-22 1993-12-10 Improved amino acid solutions for treatment of peritoneal dialysis patients

Publications (2)

Publication Number Publication Date
DE69332433D1 DE69332433D1 (de) 2002-11-28
DE69332433T2 true DE69332433T2 (de) 2003-08-14

Family

ID=25542284

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69332433T Expired - Lifetime DE69332433T2 (de) 1992-12-22 1993-12-10 Verbesserte aminosaureloesungen zur behandlung bei peritonealer dialyse

Country Status (14)

Country Link
US (3) US5670176A (de)
EP (1) EP0626845B1 (de)
JP (1) JP3483885B2 (de)
KR (1) KR100309972B1 (de)
AT (1) ATE226433T1 (de)
AU (1) AU678201B2 (de)
CA (1) CA2129998C (de)
DE (1) DE69332433T2 (de)
DK (1) DK0626845T3 (de)
ES (1) ES2185646T3 (de)
MX (1) MX9308002A (de)
NZ (1) NZ259242A (de)
SG (1) SG48704A1 (de)
WO (1) WO1994014430A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012095281A1 (de) 2011-01-13 2012-07-19 Michael Tchirikov Aminosäurezusammensetzung und deren verwendung zur behandlung von intrauteriner fetaler wachstumsrestriktion (iugr) oder zur parenteralen ernährung von extrem frühgeborenen

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2723690B1 (fr) * 1994-08-17 1996-09-27 Seb Sa Appareil de chauffe pour aliments, en particulier pour la realisation de fritures, comportant une contre-cuve
JPH1171273A (ja) * 1997-08-29 1999-03-16 Terumo Corp 腹膜透析液
WO1999034813A1 (en) * 1998-01-05 1999-07-15 Johns Hopkins University Supplement for dialysis patients
EP0970699B1 (de) * 1998-07-07 2005-09-07 Terumo Kabushiki Kaisha Lösung für die Peritonealdialyse
US7186420B2 (en) * 1999-04-26 2007-03-06 Edwards Lifesciences Corporation Multi-part substitution infusion fluids and matching anticoagulants
US8105258B2 (en) * 1999-04-26 2012-01-31 Baxter International Inc. Citrate anticoagulation system for extracorporeal blood treatments
US6743191B1 (en) 1999-04-26 2004-06-01 Edwards Lifesciences Ag Substitution infusion fluid and citrate anticoagulation
US6830692B1 (en) * 1999-09-20 2004-12-14 Degussa Ag Amino acid composition for hemodialysis
US6787039B2 (en) * 2001-01-26 2004-09-07 Degussa Ag Amino acid composition for hemodialysis
JP2002275059A (ja) * 2001-03-15 2002-09-25 Inst Of Physical & Chemical Res 腎機能障害改善用アミノ酸組成物
ITTO20020672A1 (it) * 2002-07-26 2004-01-26 Medestea Res And Production S Composizioni farmaceutiche contenenti cheto-acidi per somministrazione endoperitoneale
US20050148647A1 (en) * 2003-10-31 2005-07-07 Landry Donald W. Hemodialysis solutions and uses thereof
CN100417380C (zh) * 2005-12-14 2008-09-10 于力犁 透析液用氨基酸粉/液、其复合透析液粉/液及制备方法
US7972615B2 (en) * 2008-03-27 2011-07-05 Affinergy, Inc. Peptide compositions for coating metal medical devices with vancomycin
CN102370640A (zh) * 2010-08-18 2012-03-14 俞黎黎 血液透析用复方氨基酸制剂及含复方氨基酸的血液透析用制剂
CN105640946A (zh) * 2014-11-10 2016-06-08 天津金耀集团有限公司 氨基酸（15）乳酸盐腹膜透析液药物组合物
CN105640945A (zh) * 2014-11-10 2016-06-08 天津金耀集团有限公司 低钙必需氨基酸腹膜透析液药物组合物
CN105640948A (zh) * 2014-11-10 2016-06-08 天津金耀集团有限公司 必需氨基酸乳酸盐腹膜透析液药物组合物
CN105640947A (zh) * 2014-11-10 2016-06-08 天津金耀集团有限公司 碱性必需氨基酸乳酸盐腹膜透析液药物组合物
CN105560275A (zh) * 2014-11-10 2016-05-11 天津金耀集团有限公司 碱性低钙必需氨基酸腹膜透析液药物组合物
ES2777775T3 (es) * 2014-12-04 2020-08-06 Professional Dietetics Int Srl In Forma Abbreviata Pd Int Srl Composicion a base de aminoacidos para recuperacion de fibroelastina en tejidos conectivos dermicos
JP7063468B2 (ja) 2015-09-21 2022-05-09 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー がんに対する栄養処置
US10342824B2 (en) 2017-07-17 2019-07-09 Dr. Marlowe's Weight Loss Institute, P.L.L.C. Supplement for treating side effects of medications which cause metabolic acidosis
CA3084319A1 (en) * 2017-12-11 2019-06-20 Filtricine, Inc. Compositions, methods, kits and systems for cancer treatment and metabolic intervention therapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0077354A4 (de) * 1981-04-27 1983-09-30 Baxter Travenol Lab Dialyselösung glukose, aminosäuren und insulin enthaltend.
US4357343A (en) * 1981-06-26 1982-11-02 Baxter Travenol Laboratories, Inc. Nutritional composition for management of renal failure
CA1239586A (en) * 1984-10-02 1988-07-26 Dimitrios G. Oreopoulos Dialysis solution containing amino acids
DE3821043A1 (de) * 1988-06-22 1989-12-28 Fresenius Ag Dialysier- und spuel-loesung zur intraperitonealen verabreichung
DE3843289A1 (de) * 1988-12-22 1990-06-28 Diehl Gmbh & Co Treibspiegelmunition
DE69332959T2 (de) * 1992-02-04 2004-05-13 Baxter International Inc., Deerfield Lösungen für die Peritonealdialyse und deren Verwendung zum Verringern von Schädigungen an mesothelialen Zellen
US5589197A (en) * 1993-10-04 1996-12-31 Baxter International, Inc. Low sodium peritoneal dialysis solution

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012095281A1 (de) 2011-01-13 2012-07-19 Michael Tchirikov Aminosäurezusammensetzung und deren verwendung zur behandlung von intrauteriner fetaler wachstumsrestriktion (iugr) oder zur parenteralen ernährung von extrem frühgeborenen
EP2489408A1 (de) 2011-01-13 2012-08-22 Michael Tchirikov Aminosäurezusammensetzung und deren Verwendung zur Behandlung von fetaler Wachstumsrestriktion (IUGR) und zur parenteralen Ernährung von extrem Frühgeborenen

Also Published As

Publication number Publication date
MX9308002A (es) 1994-08-31
JPH07504210A (ja) 1995-05-11
KR950700059A (ko) 1995-01-16
KR100309972B1 (ko) 2001-12-28
AU5748894A (en) 1994-07-19
WO1994014430A1 (en) 1994-07-07
US5776503A (en) 1998-07-07
SG48704A1 (en) 1998-05-18
ATE226433T1 (de) 2002-11-15
US5698230A (en) 1997-12-16
CA2129998C (en) 2006-07-11
JP3483885B2 (ja) 2004-01-06
DE69332433D1 (de) 2002-11-28
CA2129998A1 (en) 1994-07-07
ES2185646T3 (es) 2003-05-01
AU678201B2 (en) 1997-05-22
DK0626845T3 (da) 2003-02-17
US5670176A (en) 1997-09-23
NZ259242A (en) 1997-03-24
EP0626845A1 (de) 1994-12-07
EP0626845B1 (de) 2002-10-23

Similar Documents

Publication Publication Date Title
DE69332433T2 (de) Verbesserte aminosaureloesungen zur behandlung bei peritonealer dialyse
EP0207633A3 (en) Sterilant compositions
ATE201597T1 (de) Verabreichung von riluzol zur behandlung von neuro-aids
ATE287710T1 (de) Verfahren zum modulieren der mikrozirkulation
ATE311180T1 (de) Verfahren und pharmazeutische zusammensetzung zur verabreichung von eisen an hämodialyse- oder peritonealdialyse-patienten
DE69327314T2 (de) Zusammensetzungen enthaltend Lipoprotein-Associated-Coagulation-Inhibitor (LACI) zur Herstellung eines Medikaments zur Behandlung von akuten oder chronischen Enzündungen
DE69304843T2 (de) Methode zur Behandlung von Haarausfall
DE59107536D1 (de) Arzneimittel zur behandlung von hyperlipidämie und/oder atherosklerose
ZA959377B (en) A storage stable water solution for infusion containing a thrombin inhibitor
DE69511453D1 (de) Verwendung einer Kombination von Antineoplastonen zur Herstellung eines Arzneimittels zur Behandlung der Neurofibromatose
UA28207A (uk) Спосіб лікування черепно-мозкової травми
UA31672A (uk) Спосіб лікування хворих на сепсис
UA35748A (uk) Спосіб лікування парадонтозу
BG94567A (en) Medicaments for the treatment of aids and method for its application
UA15180A (uk) Спосіб коhсервативhого лікуваhhя геhералізоваhого пародоhтиту

Legal Events

Date Code Title Description
8364 No opposition during term of opposition